Reply to Bareille et al. Are Viscoelastometric Assays of Old Generation Ready for Disposal? Comment on "Volod et al. Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices. J. Clin. Med. 2022, 11 , 860"
[...]we mentioned this phenomenon that uniquely defines COVID-19 patients. [...]a recent review of the literature using the MeSH term COVID associated coagulopathy reveals that this term was a standard descriptor for the singular observation of these patients to develop early clots that required del...
Gespeichert in:
| Veröffentlicht in: | Journal of clinical medicine 2023-01, Vol.12 (2), p.478 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 2 |
| container_start_page | 478 |
| container_title | Journal of clinical medicine |
| container_volume | 12 |
| creator | Volod, Oksana Bunch, Connor M Miller, Joseph Moore, Ernest E Moore, Hunter B Kwaan, Hau C Patel, Shivani S Wiarda, Grant Aboukhaled, Michael Thomas, Scott G Fulkerson, Daniel Erdman, Lee Tincher, Anna Walsh, Mark M |
| description | [...]we mentioned this phenomenon that uniquely defines COVID-19 patients. [...]a recent review of the literature using the MeSH term COVID associated coagulopathy reveals that this term was a standard descriptor for the singular observation of these patients to develop early clots that required delicate and closely monitored anti-coagulation [8,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37]. [...]the “1.5 to 2.5 times control” UFH therapeutic range was established is instructive regarding the history of RCTs in offering guidance for heparin anticoagulation. [...]the guidelines and algorithms are still in a state of evolution [51]. |
| doi_str_mv | 10.3390/jcm12020478 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9862366</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2768224267</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-30cd7c438311de8197af5e0569cf6f53dd4f7c152979bc616271f2339542ef753</originalsourceid><addsrcrecordid>eNpdklFvFCEQgDdGY5vaJ9_NpL6Y2FuBZWHXB8151VZzWtNoXzeUHSoXdjmBq7mf6z-RS9vzlBdI5uNjZpiieEpJWVUtebXQA2WEES6bB8U-I1JOSNVUD3fOe8VhjAuSV9NwRuXjYq8SQtacNPvF7wtcujUkD-9UQOscAiZQroRpQLi0UXt0KiY_YApWwzRGtY7gDZy7Hk5xxKCS9SNcoOrXYHyAExuXPir3FmZ-GHBMkMNHl975_t7915uVZzj4mFTa2l_DFL4GO2DY3JzjtdJrUGMPX_DX7pMneGM1xhI-lTBzdizhM_Yl5HawY6AUjqER5OhJ8cgoF_Hwbj8ovn94_212Npmfn36cTecTzUmbJhXRvdQ894vSHhvaSmVqJLVotRGmrvqeG6lpzVrZXmlBBZPUsPwHNWdoZF0dFG9uvcvV1YC9zoUH5bplLkSFdeeV7f6NjPZHd-1vurYRLH9IFry4EwT_c4UxdUNuEzqnRvSr2DEpGsY4EzKjz_9DF34VxlzehpKM0YbzTL28pXTwMQY022Qo6TbT0-1MT6af7ea_Ze9npfoDJLK9sg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2767221844</pqid></control><display><type>article</type><title>Reply to Bareille et al. Are Viscoelastometric Assays of Old Generation Ready for Disposal? Comment on "Volod et al. Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices. J. Clin. Med. 2022, 11 , 860"</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Volod, Oksana ; Bunch, Connor M ; Miller, Joseph ; Moore, Ernest E ; Moore, Hunter B ; Kwaan, Hau C ; Patel, Shivani S ; Wiarda, Grant ; Aboukhaled, Michael ; Thomas, Scott G ; Fulkerson, Daniel ; Erdman, Lee ; Tincher, Anna ; Walsh, Mark M</creator><creatorcontrib>Volod, Oksana ; Bunch, Connor M ; Miller, Joseph ; Moore, Ernest E ; Moore, Hunter B ; Kwaan, Hau C ; Patel, Shivani S ; Wiarda, Grant ; Aboukhaled, Michael ; Thomas, Scott G ; Fulkerson, Daniel ; Erdman, Lee ; Tincher, Anna ; Walsh, Mark M</creatorcontrib><description>[...]we mentioned this phenomenon that uniquely defines COVID-19 patients. [...]a recent review of the literature using the MeSH term COVID associated coagulopathy reveals that this term was a standard descriptor for the singular observation of these patients to develop early clots that required delicate and closely monitored anti-coagulation [8,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37]. [...]the “1.5 to 2.5 times control” UFH therapeutic range was established is instructive regarding the history of RCTs in offering guidance for heparin anticoagulation. [...]the guidelines and algorithms are still in a state of evolution [51].</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm12020478</identifier><identifier>PMID: 36675408</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Algorithms ; Anticoagulants ; Coronaviruses ; COVID-19 ; Laboratories ; Pandemics ; Reply ; Thromboembolism ; Viscoelasticity</subject><ispartof>Journal of clinical medicine, 2023-01, Vol.12 (2), p.478</ispartof><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-30cd7c438311de8197af5e0569cf6f53dd4f7c152979bc616271f2339542ef753</citedby><cites>FETCH-LOGICAL-c409t-30cd7c438311de8197af5e0569cf6f53dd4f7c152979bc616271f2339542ef753</cites><orcidid>0000-0002-1561-6161 ; 0000-0001-6285-7585 ; 0000-0002-5795-1144 ; 0000-0002-5733-6248 ; 0000-0002-8566-7001 ; 0000-0002-0419-4848 ; 0009-0001-1244-072X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862366/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862366/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36675408$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Volod, Oksana</creatorcontrib><creatorcontrib>Bunch, Connor M</creatorcontrib><creatorcontrib>Miller, Joseph</creatorcontrib><creatorcontrib>Moore, Ernest E</creatorcontrib><creatorcontrib>Moore, Hunter B</creatorcontrib><creatorcontrib>Kwaan, Hau C</creatorcontrib><creatorcontrib>Patel, Shivani S</creatorcontrib><creatorcontrib>Wiarda, Grant</creatorcontrib><creatorcontrib>Aboukhaled, Michael</creatorcontrib><creatorcontrib>Thomas, Scott G</creatorcontrib><creatorcontrib>Fulkerson, Daniel</creatorcontrib><creatorcontrib>Erdman, Lee</creatorcontrib><creatorcontrib>Tincher, Anna</creatorcontrib><creatorcontrib>Walsh, Mark M</creatorcontrib><title>Reply to Bareille et al. Are Viscoelastometric Assays of Old Generation Ready for Disposal? Comment on "Volod et al. Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices. J. Clin. Med. 2022, 11 , 860"</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>[...]we mentioned this phenomenon that uniquely defines COVID-19 patients. [...]a recent review of the literature using the MeSH term COVID associated coagulopathy reveals that this term was a standard descriptor for the singular observation of these patients to develop early clots that required delicate and closely monitored anti-coagulation [8,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37]. [...]the “1.5 to 2.5 times control” UFH therapeutic range was established is instructive regarding the history of RCTs in offering guidance for heparin anticoagulation. [...]the guidelines and algorithms are still in a state of evolution [51].</description><subject>Algorithms</subject><subject>Anticoagulants</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Laboratories</subject><subject>Pandemics</subject><subject>Reply</subject><subject>Thromboembolism</subject><subject>Viscoelasticity</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdklFvFCEQgDdGY5vaJ9_NpL6Y2FuBZWHXB8151VZzWtNoXzeUHSoXdjmBq7mf6z-RS9vzlBdI5uNjZpiieEpJWVUtebXQA2WEES6bB8U-I1JOSNVUD3fOe8VhjAuSV9NwRuXjYq8SQtacNPvF7wtcujUkD-9UQOscAiZQroRpQLi0UXt0KiY_YApWwzRGtY7gDZy7Hk5xxKCS9SNcoOrXYHyAExuXPir3FmZ-GHBMkMNHl975_t7915uVZzj4mFTa2l_DFL4GO2DY3JzjtdJrUGMPX_DX7pMneGM1xhI-lTBzdizhM_Yl5HawY6AUjqER5OhJ8cgoF_Hwbj8ovn94_212Npmfn36cTecTzUmbJhXRvdQ894vSHhvaSmVqJLVotRGmrvqeG6lpzVrZXmlBBZPUsPwHNWdoZF0dFG9uvcvV1YC9zoUH5bplLkSFdeeV7f6NjPZHd-1vurYRLH9IFry4EwT_c4UxdUNuEzqnRvSr2DEpGsY4EzKjz_9DF34VxlzehpKM0YbzTL28pXTwMQY022Qo6TbT0-1MT6af7ea_Ze9npfoDJLK9sg</recordid><startdate>20230106</startdate><enddate>20230106</enddate><creator>Volod, Oksana</creator><creator>Bunch, Connor M</creator><creator>Miller, Joseph</creator><creator>Moore, Ernest E</creator><creator>Moore, Hunter B</creator><creator>Kwaan, Hau C</creator><creator>Patel, Shivani S</creator><creator>Wiarda, Grant</creator><creator>Aboukhaled, Michael</creator><creator>Thomas, Scott G</creator><creator>Fulkerson, Daniel</creator><creator>Erdman, Lee</creator><creator>Tincher, Anna</creator><creator>Walsh, Mark M</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1561-6161</orcidid><orcidid>https://orcid.org/0000-0001-6285-7585</orcidid><orcidid>https://orcid.org/0000-0002-5795-1144</orcidid><orcidid>https://orcid.org/0000-0002-5733-6248</orcidid><orcidid>https://orcid.org/0000-0002-8566-7001</orcidid><orcidid>https://orcid.org/0000-0002-0419-4848</orcidid><orcidid>https://orcid.org/0009-0001-1244-072X</orcidid></search><sort><creationdate>20230106</creationdate><title>Reply to Bareille et al. Are Viscoelastometric Assays of Old Generation Ready for Disposal? Comment on "Volod et al. Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices. J. Clin. Med. 2022, 11 , 860"</title><author>Volod, Oksana ; Bunch, Connor M ; Miller, Joseph ; Moore, Ernest E ; Moore, Hunter B ; Kwaan, Hau C ; Patel, Shivani S ; Wiarda, Grant ; Aboukhaled, Michael ; Thomas, Scott G ; Fulkerson, Daniel ; Erdman, Lee ; Tincher, Anna ; Walsh, Mark M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-30cd7c438311de8197af5e0569cf6f53dd4f7c152979bc616271f2339542ef753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Algorithms</topic><topic>Anticoagulants</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Laboratories</topic><topic>Pandemics</topic><topic>Reply</topic><topic>Thromboembolism</topic><topic>Viscoelasticity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Volod, Oksana</creatorcontrib><creatorcontrib>Bunch, Connor M</creatorcontrib><creatorcontrib>Miller, Joseph</creatorcontrib><creatorcontrib>Moore, Ernest E</creatorcontrib><creatorcontrib>Moore, Hunter B</creatorcontrib><creatorcontrib>Kwaan, Hau C</creatorcontrib><creatorcontrib>Patel, Shivani S</creatorcontrib><creatorcontrib>Wiarda, Grant</creatorcontrib><creatorcontrib>Aboukhaled, Michael</creatorcontrib><creatorcontrib>Thomas, Scott G</creatorcontrib><creatorcontrib>Fulkerson, Daniel</creatorcontrib><creatorcontrib>Erdman, Lee</creatorcontrib><creatorcontrib>Tincher, Anna</creatorcontrib><creatorcontrib>Walsh, Mark M</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Volod, Oksana</au><au>Bunch, Connor M</au><au>Miller, Joseph</au><au>Moore, Ernest E</au><au>Moore, Hunter B</au><au>Kwaan, Hau C</au><au>Patel, Shivani S</au><au>Wiarda, Grant</au><au>Aboukhaled, Michael</au><au>Thomas, Scott G</au><au>Fulkerson, Daniel</au><au>Erdman, Lee</au><au>Tincher, Anna</au><au>Walsh, Mark M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reply to Bareille et al. Are Viscoelastometric Assays of Old Generation Ready for Disposal? Comment on "Volod et al. Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices. J. Clin. Med. 2022, 11 , 860"</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2023-01-06</date><risdate>2023</risdate><volume>12</volume><issue>2</issue><spage>478</spage><pages>478-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>[...]we mentioned this phenomenon that uniquely defines COVID-19 patients. [...]a recent review of the literature using the MeSH term COVID associated coagulopathy reveals that this term was a standard descriptor for the singular observation of these patients to develop early clots that required delicate and closely monitored anti-coagulation [8,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37]. [...]the “1.5 to 2.5 times control” UFH therapeutic range was established is instructive regarding the history of RCTs in offering guidance for heparin anticoagulation. [...]the guidelines and algorithms are still in a state of evolution [51].</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>36675408</pmid><doi>10.3390/jcm12020478</doi><orcidid>https://orcid.org/0000-0002-1561-6161</orcidid><orcidid>https://orcid.org/0000-0001-6285-7585</orcidid><orcidid>https://orcid.org/0000-0002-5795-1144</orcidid><orcidid>https://orcid.org/0000-0002-5733-6248</orcidid><orcidid>https://orcid.org/0000-0002-8566-7001</orcidid><orcidid>https://orcid.org/0000-0002-0419-4848</orcidid><orcidid>https://orcid.org/0009-0001-1244-072X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2077-0383 |
| ispartof | Journal of clinical medicine, 2023-01, Vol.12 (2), p.478 |
| issn | 2077-0383 2077-0383 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9862366 |
| source | MDPI - Multidisciplinary Digital Publishing Institute; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access |
| subjects | Algorithms Anticoagulants Coronaviruses COVID-19 Laboratories Pandemics Reply Thromboembolism Viscoelasticity |
| title | Reply to Bareille et al. Are Viscoelastometric Assays of Old Generation Ready for Disposal? Comment on "Volod et al. Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices. J. Clin. Med. 2022, 11 , 860" |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T22%3A15%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reply%20to%20Bareille%20et%20al.%20Are%20Viscoelastometric%20Assays%20of%20Old%20Generation%20Ready%20for%20Disposal?%20Comment%20on%20%22Volod%20et%20al.%20Viscoelastic%20Hemostatic%20Assays:%20A%20Primer%20on%20Legacy%20and%20New%20Generation%20Devices.%20J.%20Clin.%20Med.%202022,%2011%20,%20860%22&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Volod,%20Oksana&rft.date=2023-01-06&rft.volume=12&rft.issue=2&rft.spage=478&rft.pages=478-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm12020478&rft_dat=%3Cproquest_pubme%3E2768224267%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2767221844&rft_id=info:pmid/36675408&rfr_iscdi=true |